Discovering and developing innovative therapeutics for CNS disorders

Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company. Our shares are listed on the SIX Swiss Exchange (NWRN). Our mission is to discover, develop and commercialise novel drugs to treat diseases of the Central Nervous System (CNS) and pain.

Investors

Financial Calendar

Publication of Annual Report 2011:  May 31, 2012

 

Press and Analyst Conference: May 31, 2012

 

Annual Shareholders' meeting:  June 28, 2012, Milan

 

Half year report 2012:  September 10, 2012